(Insulin icodec + Semaglutide) is a recombinant peptide and recombinant protein commercialized by Novo Nordisk, with a leading Phase III program in Type 2 Diabetes.
CDC Issues New Guidance on Identifying, Responding to Suicide Clusters
The CDC has issued new guidance — its first since 1988 — on identifying and responding to clusters of suicide, as tens of thousands of